Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PG vs GSK✓SelectedUSD · GSKPG vs GSK performance historyLatest closeAs of-1.43%11/19
Stock and ETF performance explorer

PG vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+30.0%
GSK return
+39.6%
Excess return
-9.5%
Maximum drawdown
-23.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.4%-1.6%+0.1%-1.1%
7D-0.1%-4.7%+4.6%+1.1%
30D+6.1%-4.7%+10.8%+7.3%
3M+17.0%-8.8%+25.8%+19.5%
6M+20.5%-4.6%+25.1%+21.6%
YTD+20.5%+1.0%+19.5%+20.0%
1Y+17.5%+6.9%+10.6%+15.6%
3Y+20.3%+52.5%-32.3%+7.2%
5Y+30.0%+40.3%-10.2%+12.9%
All+30.0%+39.6%-9.5%+12.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling